Contents

Current Vascular Pharmacology, Volume 4 - Number 2

The Management of Phosphodiesterase-5 (PDE5) Inhibitor Failure

, 4(2): 89 - 93

David H.W. Lau, Sashi Kommu, Faiz H. Mumtaz, Robert J. Morgan, Cecil S. Thompson and Dimitri P. Mikhailidis


DOI: 10.2174/157016106776359871




Pharmacological Management of No Reflow During Percutaneous Coronary Intervention

, 4(2): 95 - 100

Italo Porto, Vaishali Ashar and Andrew R.J. Mitchell


DOI: 10.2174/157016106776359835




Plasminogen Activator System and Vascular Disease

, 4(2): 101 - 116

Suzanne M. Nicholl, Elisa Roztocil and Mark G. Davies


DOI: 10.2174/157016106776359880




Migraine: Current Therapeutic Targets and Future Avenues

, 4(2): 117 - 128

D. K. Arulmozhi, A. Veeranjaneyulu and S. L. Bodhankar


DOI: 10.2174/157016106776359853




Pharmacotherapy of Abdominal Aortic Aneurysms

, 4(2): 129 - 149

Joe Dawson, Edward Choke, Saiqa Sayed, Gillian Cockerill, Ian Loftus and Matt M. Thompson


DOI: 10.2174/157016106776359817




Fine Tuning Therapeutic Targeting of the Sphingolipid Biosynthetic Pathway to Treat Atherosclerosis

, 4(2): 151 - 154

W. S. Kim, Charles E. Chalfant and Brett Garner


DOI: 10.2174/157016106776359844




Blood Pressure Reduction in the Primary and Secondary Prevention of Stroke

, 4(2): 155 - 160

Seth I. Sokol, John R. Kapoor and JoAnne M. Foody


DOI: 10.2174/157016106776359862




Postprandial Hypotension - Novel Insights into Pathophysiology and Therapeutic Implications

, 4(2): 161 - 171

Diana Gentilcore, Karen L. Jones, Deirdre G. O'Donovan and Michael Horowitz


DOI: 10.2174/157016106776359826




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science